These observations suggest a potential causative role for CD24 in cancer development, as demonstrated by experiments using small-interfering RNA to silence CD24 expression in tumor cells, leading to a direct impact on cell proliferation and survival in tissue culture (236). The gene discussed is CD24; the disease is neoplasm.